Zynerba Pharmaceuticals Inc. (ZYNE) surged 14.19% or 1.13 to $9.11. It is nearly 315854 shares traded, which is 99.06% compare to the average total volume 318849. The market cap of ZYNE is $123.57 million. The year to date change is -38.59%. The 52 week price range is from $5.42 to $25.95. Price of ZYNE have changed -8.06% during last week. It have changed -21.15% over last month, -38.59% over last 3 months, -8.17% over last 6 months and -60.73% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ZYNE is 10.41. It is 14.27% above current price. The 200-day Moving Averages for ZYNE is 11.38. It is 24.92% above current price. The 52-week High is 25.95. It is 184.85% from the current price. The 52-week Low is 5.42. It is -40.50% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ZYNE is 7.8 on 2018-03-15. Short % to float is 22.89%. There are some statistics of ZYNE. It is has market cap $123.57 million. The share outstanding is 13.56 million. The average volume is 318849. The percent of top 15 Institution holding is 22.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ZYNE is -67.61%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ZYNE is -57.81%.